Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Array Biopharma Inc (ARRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,131,865
  • Shares Outstanding, K 197,030
  • Annual Sales, $ 150,850 K
  • Annual Income, $ -116,820 K
  • 36-Month Beta 1.92
  • Price/Sales 14.46
  • Price/Cash Flow N/A
  • Price/Book 9.54

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.21 +5.97%
on 11/14/17
11.91 -9.15%
on 11/17/17
-0.18 (-1.64%)
since 11/10/17
3-Month
9.65 +12.12%
on 09/14/17
12.68 -14.67%
on 10/02/17
+0.85 (+8.53%)
since 09/12/17
52-Week
6.73 +60.77%
on 05/09/17
13.40 -19.25%
on 02/10/17
+2.10 (+24.08%)
since 12/12/16

Most Recent Stories

More News
Today's Research Reports on Trending Tickers: Array BioPharma and Verastem, Inc.

NEW YORK, NY / ACCESSWIRE / December 12, 2017 / Despite the recent bombing in New York City, U.S. markets rose higher Monday on the strength of technology and energy shares. Monday also marked the first...

ARRY : 10.82 (-2.26%)
VSTM : 3.72 (+3.33%)
ARRY EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased...

ARRY : 10.82 (-2.26%)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP:

ARRY : 10.82 (-2.26%)
Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock?

Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.

ARRY : 10.82 (-2.26%)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Array Biopharma Inc. and Certain Officers - ARRY

NEW YORK, NY / ACCESSWIRE / December 9, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Array Biopharma Inc. ("Array" or the "Company") (NASDAQ: ARRY) and certain of its...

ARRY : 10.82 (-2.26%)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Array Biopharma, Inc. (ARRY) & Lead Plaintiff Deadline: January 22, 2018

NEW YORK, NY / ACCESSWIRE / December 8, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Array Biopharma, Inc. ("Array" or the "Company") (NASDAQ:...

ARRY : 10.82 (-2.26%)
The Klein Law Firm Notifies Shareholders of a Class Action Filed on Behalf of Array Biopharma Inc. Shareholders and a Lead Plaintiff Deadline of January 22, 2018 (ARAY)

The Klein Law Firm notifies shareholders that a class action complaint has been filed on behalf of shareholders of Array Biopharma Inc. (NASDAQ:ARRY) who purchased shares between December 16, 2015 and...

ARRY : 10.82 (-2.26%)
New Research Coverage Highlights Array BioPharma, Impax Laboratories, Baxter International, Timken Steel, National Health Investors, and Donaldson -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Array BioPharma Inc. (NASDAQ:ARRY),...

ARRY : 10.82 (-2.26%)
IPXL : 17.85 (+7.21%)
BAX : 64.31 (+0.27%)
TKR : 48.65 (+0.52%)
DCI : 48.51 (-1.64%)
TMST : 13.54 (+0.22%)
NHI : 79.02 (+0.69%)
Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020

Array BioPharma Inc. (Nasdaq: ARRY) ("Array" or the "Company") today announced that it has called for redemption approximately $6.2 million of its 3.00% Convertible Senior Notes due 2020 (the "2020 Notes")...

ARRY : 10.82 (-2.26%)
ARRY INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Array Biopharma Inc. and a Lead Plaintiff Deadline of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased...

ARRY : 10.82 (-2.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory...

See More

Key Turning Points

2nd Resistance Point 11.42
1st Resistance Point 11.12
Last Price 10.82
1st Support Level 10.60
2nd Support Level 10.38

See More

52-Week High 13.40
Fibonacci 61.8% 10.85
Last Price 10.82
Fibonacci 50% 10.06
Fibonacci 38.2% 9.28
52-Week Low 6.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.